Correction: ELK3-CYFIP2 axis-mediated actin remodeling modulates metastasis and natural killer cell responses in triple-negative breast cancer

被引:0
|
作者
Seung Hee Choi [1 ]
Hye Jung Jang [2 ]
Joo Dong Park [2 ]
Ki Seo Ryu [1 ]
Eunchong Maeng [1 ]
Seohyun Cho [1 ]
Hail Park [1 ]
Hae-Yun Jung [3 ]
Kyung-Soon Park [1 ]
机构
[1] CHA University,Department of Biomedical Science
[2] Sungkyunkwan University,Department of Integrative Biotechnology
[3] Korea Institute of Radiological and Medical Sciences,Division of Radiation Biomedical Research
关键词
D O I
10.1186/s13046-025-03388-6
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer
    Yu, Tian-Jian
    Liu, Ying-Ying
    Li, Xiao-Guang
    Lian, Bi
    Lu, Xun-Xi
    Jin, Xi
    Shao, Zhi-Ming
    Hu, Xin
    Di, Gen-Hong
    Jiang, Yi-Zhou
    CANCER RESEARCH, 2021, 81 (21) : 5491 - 5505
  • [22] Lipid-Based Nanoparticles Fused with Natural Killer Cell Plasma Membrane Proteins for Triple-Negative Breast Cancer Therapy
    Won, Eun-Jeong
    Lee, Myungchul
    Lee, Eui-Kyung
    Baek, Seung-Hoon
    Yoon, Tae-Jong
    PHARMACEUTICS, 2024, 16 (09)
  • [23] Novel delivery of sorafenib by natural killer cell-derived exosomes-enhanced apoptosis in triple-negative breast cancer
    Hashemi, Zahra Sadat
    Ghavami, Mahlegha
    Kiaie, Seyed Hossein
    Mohammadi, Fateme
    Barough, Mahdieh Shokrollahi
    Khalili, Saeed
    Hosseini-Farjam, Zahra
    Mossahebi-Mohammadi, Majid
    Sheidary, Alireza
    Ghavamzadeh, Ardeshir
    Forooshani, Ramin Sarrami
    NANOMEDICINE, 2023, 18 (05) : 437 - 453
  • [24] Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer
    Liu, Zundong
    Ding, Mingji
    Qiu, Pengjun
    Pan, Kelun
    Guo, Qiaonan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [25] A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer
    Wu, Song
    Lu, Jibu
    Zhu, Hongbo
    Wu, Feiyue
    Mo, Yunxian
    Xie, Liming
    Song, Cailu
    Liu, Lingrui
    Xie, Xiaoming
    Li, Yuehua
    Lin, Huan
    Tang, Hailin
    CANCER LETTERS, 2024, 581
  • [26] SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis
    Jiang, Ke
    Liu, Peng
    Xu, Huizhe
    Liang, Dapeng
    Fang, Kun
    Du, Sha
    Cheng, Wei
    Ye, Leiguang
    Liu, Tong
    Zhang, Xiaohong
    Gong, Peng
    Shao, Shujuan
    Wang, Yifei
    Meng, Songshu
    ONCOGENE, 2020, 39 (27) : 5015 - 5030
  • [27] SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis
    Ke Jiang
    Peng Liu
    Huizhe Xu
    Dapeng Liang
    Kun Fang
    Sha Du
    Wei Cheng
    Leiguang Ye
    Tong Liu
    Xiaohong Zhang
    Peng Gong
    Shujuan Shao
    Yifei Wang
    Songshu Meng
    Oncogene, 2020, 39 : 5015 - 5030
  • [28] Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity
    Choi, Hoon Sik
    Ko, Young Shin
    Jin, Hana
    Kang, Ki Mun
    Ha, In Bong
    Jeong, Hojin
    Lee, Jeong-hee
    Jeong, Bae Kwon
    Kim, Hye Jung
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [29] Combined peripheral natural killer cell and circulating tumor cell enumeration enhance prognostic efficiency in patients with metastatic triple-negative breast cancer
    Xiaoran Liu
    Ran Ran
    Bin Shao
    Hope S.Rugo
    Yanlian Yang
    Zhiyuan Hu
    Zewen Wei
    Fengling Wan
    Weiyao Kong
    Guohong Song
    Hanfang Jiang
    Xu Liang
    Ruyan Zhang
    Ying Yan
    Guobing Xu
    Huiping Li
    Chinese Journal of Cancer Research, 2018, 30 (03) : 315 - 326
  • [30] Combined peripheral natural killer cell and circulating tumor cell enumeration enhance prognostic efficiency in patients with metastatic triple-negative breast cancer
    Liu, Xiaoran
    Ran, Ran
    Shao, Bin
    Rugo, Hope S.
    Yang, Yanlian
    Hu, Zhiyuan
    Wei, Zewen
    Wan, Fengling
    Kong, Weiyao
    Song, Guohong
    Jiang, Hanfang
    Liang, Xu
    Zhang, Ruyan
    Yan, Ying
    Xu, Guobing
    Li, Huiping
    CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (03) : 315 - +